VERACYTE INC's ticker is VCYT and the CUSIP is 92337F107. A total of 222 filers reported holding VERACYTE INC in Q4 2020. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $465,367 | +4.1% | 20,844 | +18.8% | 0.00% | 0.0% |
| Q2 2023 | $446,865 | +15.4% | 17,551 | +1.0% | 0.00% | 0.0% |
| Q1 2023 | $387,331 | -3.6% | 17,380 | +2.5% | 0.00% | 0.0% |
| Q4 2022 | $401,810 | +148.0% | 16,954 | +74.0% | 0.00% | – |
| Q3 2022 | $162,000 | +11.7% | 9,745 | +33.6% | 0.00% | – |
| Q2 2022 | $145,000 | -12.7% | 7,295 | +14.1% | 0.00% | – |
| Q1 2022 | $166,000 | -34.1% | 6,396 | +5.0% | 0.00% | – |
| Q4 2021 | $252,000 | +8.2% | 6,092 | +21.8% | 0.00% | – |
| Q3 2021 | $233,000 | +48.4% | 5,002 | +27.6% | 0.00% | – |
| Q2 2021 | $157,000 | +48.1% | 3,919 | +100.9% | 0.00% | – |
| Q1 2021 | $106,000 | -5.4% | 1,951 | -15.4% | 0.00% | – |
| Q4 2020 | $112,000 | -77.6% | 2,307 | -85.0% | 0.00% | -100.0% |
| Q3 2020 | $499,000 | +508.5% | 15,341 | +384.4% | 0.00% | – |
| Q2 2020 | $82,000 | +60.8% | 3,167 | +51.5% | 0.00% | – |
| Q1 2020 | $51,000 | – | 2,090 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | 123,030 | $2,920 | 3.08% |
| ARK Investment Management | 8,300,241 | $196,964,719 | 1.71% |
| EFG Asset Management (North America) Corp. | 291,328 | $7,018,091 | 1.58% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $4,746,000 | 1.36% |
| Granahan Investment Management | 1,763,266 | $41,842,302 | 1.28% |
| Nikko Asset Management Americas, Inc. | 3,064,445 | $72,596,702 | 1.05% |
| ArrowMark Colorado Holdings LLC | 2,789,670 | $66,198,869 | 0.79% |
| CLOUGH CAPITAL PARTNERS L P | 316,976 | $7,521,840 | 0.76% |
| Parkman Healthcare Partners LLC | 117,726 | $2,793,638 | 0.74% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 139,562 | $3,312 | 0.52% |